
Pnoe
PNOĒ empowers health professionals to deliver science backed bio-optimization through the first easy-to-use, clinical grade breath analysis device. By combining a non-invasive 8-minute test with an AI-driven software ecosystem, PNOĒ translates complex metabolic data into highly personalized nutrition, training, and longevity programming.
Executive Brief
For over a century, breath analysis (often known as VO2 Max or resting metabolic rate testing) has been the gold standard for quantifying aging, prescribing nutrition, and evaluating critical systems like the heart, lungs, and cells. Until recently, this powerful assessment was confined to sophisticated clinics and research hospitals.
PNOĒ changed that by introducing the first portable, clinical-grade breath analysis device paired with a comprehensive software ecosystem and dedicated expert support. Through a non-invasive, 8-minute breath test, PNOĒ analyzes 23 distinct biomarkers without requiring any lab work or blood draws.
Using this data, PNOĒ’s AI-powered platform instantly translates raw diagnostics into highly personalized nutrition, training, breathwork, and bio-optimization programs. Today, PNOĒ is trusted by thousands of health professionals, leading universities, and world-class athletes to personalize patient care, quantify progress, and scale integrative health practices.
Founder(s) Apostolos Atsalakis & Panagiotis Papadiamantis
Stage Late-Stage Venture
Location Greece, USA
LONGEVITY AI